Safety of Flunotinib Maleate Tablets for the Treatment of Patients With Myeloproliferative
Phase 1
Recruiting
- Conditions
- Myelofibrosis，MFMyeloproliferative Neoplasm (MPN)
- Interventions
- Drug: flonoltinib 225mgDrug: flonoltinib 100mgDrug: flonoltinib 25mgDrug: flonoltinib 50mgDrug: flonoltinib 325mgDrug: flonoltinib 150mg
- First Posted Date
- 2021-12-10
- Last Posted Date
- 2023-09-26
- Lead Sponsor
- Chengdu Zenitar Biomedical Technology Co., Ltd
- Target Recruit Count
- 31
- Registration Number
- NCT05153343
- Locations
- 🇨🇳
West China Hospital Sichuan University, Chengdu, Sichuan, China
Study of Flonoltinib Maleate Tablets in the Treatment of Proliferative Bone Marrow Tumors
Phase 1
- Conditions
- Myelofibrosis，MFMyeloproliferative Neoplasm (MPN)
- Interventions
- Drug: flonoltinib 25mgDrug: flonoltinib 50mgDrug: flonoltinib 100mgDrug: flonoltinib 150mgDrug: flonoltinib 225mgDrug: flonoltinib 325mg
- First Posted Date
- 2021-11-10
- Last Posted Date
- 2021-11-10
- Lead Sponsor
- Chengdu Zenitar Biomedical Technology Co., Ltd
- Target Recruit Count
- 31
- Registration Number
- NCT05115344
© Copyright 2025. All Rights Reserved by MedPath